TB500 Fragment (1723), also known as fequesetide, is a highpurity, research-grade heptapeptide derived from the active domain of thymosin beta4 (TB4), engineered to model actin regulation, cell migration, and tissue repair in controlled experimental systems
With respect to dosage, the average reductions were: 2000 mcg: 71.5% (single data point) 1,000 mcg: 31.8% Although limited data are available for higher dosages, the findings support the efficacy of both oral and non-oral B12 formulations in modulating homocysteine levels
As the nutrients are used up by the body, the metabolic boost gradually fades, which is why consistent weekly treatments produce the best cumulative results
BPC-157 (Body Protective Compound) is a peptide originally isolated from human gastric juice
Verify local laws before purchasing
All products are intended strictly for research use only